BioLife Solutions BLFS Accrued expenses and other current liabilities
Accrued expenses and other current liabilities at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept blfs:AccruedExpensesAndOtherCurrentLiabilities.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's accrued expenses and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's accrued expenses and other current liabilities?
- BioLife Solutions (BLFS) reported accrued expenses and other current liabilities of $7.58M in Q1 2026.
- How has BioLife Solutions's accrued expenses and other current liabilities changed year-over-year?
- BioLife Solutions's accrued expenses and other current liabilities decreased by 7.8% year-over-year, from $8.21M to $7.58M.
- What is the long-term trend for BioLife Solutions's accrued expenses and other current liabilities?
- Over 5 years (2020 to 2025), BioLife Solutions's accrued expenses and other current liabilities has grown at a 21.4% compound annual growth rate (CAGR), from $4.54M to $11.97M.
- What does accrued expenses and other current liabilities mean?
- This represents short-term obligations for goods or services received but not yet invoiced or paid, alongside miscellaneous current liabilities. It serves as a key indicator of near-term operational cash outflows and the company's management of short-term working capital requirements. A significant change in this balance may signal shifts in operational scale, timing of vendor payments, or changes in accrual accounting estimates.